Rain Oncology to cut 65% of staff after milademetan Phase 3 trial failure

cafead

Administrator
Staff member
  • cafead   May 31, 2023 at 11:12: AM
via The late-stage precision oncology company said it would lay off 65% of its workforce and halt the launch of a Phase 1/2 MANTRA-4 combination trial.

article source